GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Adline Chem Lab Ltd (BOM:524604) » Definitions » Total Receivables

Adline Chem Lab (BOM:524604) Total Receivables : ₹0.00 Mil (As of . 20)


View and export this data going back to 1995. Start your Free Trial

What is Adline Chem Lab Total Receivables?

Adline Chem Lab's Total Receivables for the quarter that ended in . 20 was ₹0.00 Mil.


Adline Chem Lab Total Receivables Historical Data

The historical data trend for Adline Chem Lab's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adline Chem Lab Total Receivables Chart

Adline Chem Lab Annual Data
Trend
Total Receivables

Adline Chem Lab Semi-Annual Data
Total Receivables

Adline Chem Lab Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables


Adline Chem Lab Total Receivables Related Terms

Thank you for viewing the detailed overview of Adline Chem Lab's Total Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Adline Chem Lab Business Description

Traded in Other Exchanges
N/A
Address
403, S.G. Highway, Sarthik-II, Opposite Rajpath Club, Shapath-I Complex, Bodakdev, Ahmedabad, GJ, IND, 380054
Adline Chem Lab Ltd is mainly engaged in the manufacturing and trading of pharmaceutical products. The segments of the group are pharmaceutical formulations and Nutraceuticals and Dietary. The company's products are offered to the domestic market, international market, veterinary, educational supplements, and contract manufacturing.

Adline Chem Lab Headlines

No Headlines